Inactivation of tumor suppressor genes p15INK4b and p16INK4a in primary cutaneous B cell lymphoma

Journal of Investigative Dermatology

Volumn 118, Issue 6, 2002, Pages 941-948

  Child, Fiona J ^a   Scarisbrick, Julia J ^a   Calonje, Eduardo ^a   Orchard, Guy ^a   Russell Jones, Robin ^a   Whittaker, Sean J ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Chromosome 9; Loss of heterozygosity; Promotor hypermethylation

Indexed keywords

ISOPROTEIN; PRIMER DNA; PROTEIN P15; PROTEIN P16;

ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DNA METHYLATION; EXON; FEMALE; GENE IDENTIFICATION; GENE INACTIVATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE HYPERPLASIA; LYMPHOCYTIC INFILTRATION; LYMPHOPROLIFERATIVE DISEASE; MALE; MICROSATELLITE MARKER; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SCHOOL CHILD; SINGLE STRAND CONFORMATION POLYMORPHISM; SKIN LYMPHOMA; TUMOR SUPPRESSOR GENE;

EID: 0036277732     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2002.01785.x     Document Type: Article

References (29)

1. INK4a (MTS1) in B-cell and T-cell lymphomas
2. Allelic deletion at 9p21-22 in primary cutaneous CD30+ve large cell lymphoma
3. Homozygous deletions of 9p21 in primary human bladder tumours detected by comparative multiplex polymerase chain reaction
4. Bcl-2 protein expression and correlation with the interchromosomal 14; 18 translocation in cutaneous lymphomas and pseudolymphomas
5. Absence of the t(14; 18) translocation in primary cutaneous B-cell lymphoma
6. Molecular analysis of the immunoglobulin heavy chain gene in the diagnosis of primary cutaneous B-cell lymphoma
7. Refined mapping of genomic rearrangements involving the short arm of chromosome 9 in acute lymphoblastic leukaemias and other haematologic malignancies
8. Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle centre lymphoma
9. A gene hypermethylation profile in human cancer
10. Cutaneous follicular B-cell lymphoma
11. Deletions of the cyclin dependent kinase inhibitor genes p16INK4a and p15INK4b in non-Hodgkin’s lymphomas
12. Primary cutaneous B-cell lymphoma: A clinical, histological, phenotypic and genotypic study of 21 cases
13. Mature B-cell neoplasms
14. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
15. INK4a characterize the major types of haematological malignancies
16. INK4a gene inactivation in childhood acute lymphocytic leukemia
17. Role of the cyclin dependent kinase inhibitors in the development of cancer
18. Analysis of the p16 gene, CDKN 2, in 17 Australian melanoma kindreds
19. CDKN2A (P16 (INK4a)) and CDK4 mutation analysis in 131 Australian melanoma probands: Effect of family history and multiple primary melanomas
20. Cancer epigenetics comes of age
21. A cell cycle regulator potentially involved in genesis of many tumour types
22. p16 INK4a gene alterations are frequent in lesions of mycosis fungoides
23. Homozygous loss of the cyclin-dependent kinase 4 inhibitor (p16) gene in human leukaemias
24. INK4a in mycosis fungoides
25. INK4a gene inactivation by deletions, mutations and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin’s lymphomas
26. Frequent abnormalities of the P15 and P16 genes in mycosis fungoides and Sezary syndrome
27. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
28. Loss of p16/INK4A protein expression in non-Hodgkin’s lymphomas is a frequent finding associated with tumour progression
29. Molecular analysis of the t(14; 18) chromosomal translocation in malignant lymphomas